- Home
- RYI vs ARCT Comparison
RYI vs ARCT Comparison
Compare RYI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- ARCT
- Stock Information
- Founded
- RYI 1842
- ARCT 2013
- Country
- RYI United States
- ARCT United States
- Employees
- RYI N/A
- ARCT N/A
- Industry
- RYI Metal Fabrications
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- RYI Industrials
- ARCT Health Care
- Exchange
- RYI Nasdaq
- ARCT Nasdaq
- Market Cap
- RYI 699.3M
- ARCT 298.3M
- IPO Year
- RYI N/A
- ARCT N/A
- Fundamental
- Price
- RYI $22.75
- ARCT $13.27
- Analyst Decision
- RYI Hold
- ARCT Strong Buy
- Analyst Count
- RYI 1
- ARCT 8
- Target Price
- RYI $25.00
- ARCT $52.83
- AVG Volume (30 Days)
- RYI 280.3K
- ARCT 474.4K
- Earning Date
- RYI 07-29-2025
- ARCT 08-04-2025
- Dividend Yield
- RYI 3.28%
- ARCT N/A
- EPS Growth
- RYI N/A
- ARCT N/A
- EPS
- RYI N/A
- ARCT N/A
- Revenue
- RYI $4,495,200,000.00
- ARCT $143,680,000.00
- Revenue This Year
- RYI $0.35
- ARCT N/A
- Revenue Next Year
- RYI $3.40
- ARCT $34.79
- P/E Ratio
- RYI N/A
- ARCT N/A
- Revenue Growth
- RYI N/A
- ARCT 15.38
- 52 Week Low
- RYI $17.18
- ARCT $8.04
- 52 Week High
- RYI $27.41
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- RYI 57.27
- ARCT 51.35
- Support Level
- RYI $23.03
- ARCT $13.25
- Resistance Level
- RYI $24.28
- ARCT $15.20
- Average True Range (ATR)
- RYI 0.86
- ARCT 0.97
- MACD
- RYI 0.17
- ARCT -0.04
- Stochastic Oscillator
- RYI 75.29
- ARCT 30.20
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.